Make Scientific Journals More Responsive-And Responsible

Scientific journals welcome new subscribers without reservation. It is a pity that many are far less welcom ing to the other group of people on whom they they depend--their authors. In one sense, it is inevitable that journals do not take pains to accommodate authors. Only a minority of scientists can succeed in having their work regularly published in the most respected and widely read journals in their field. Many papers are rejected by one or more journals before being accepted. What I d

Written byAndrew Herxheimer
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Scientific journals welcome new subscribers without reservation. It is a pity that many are far less welcom ing to the other group of people on whom they they depend--their authors.

In one sense, it is inevitable that journals do not take pains to accommodate authors. Only a minority of scientists can succeed in having their work regularly published in the most respected and widely read journals in their field. Many papers are rejected by one or more journals before being accepted. What I don’t understand, however, is why the editorial process has to be so wearying and frustrating for scientists. All of us probably have stories to tell about editors who took months to acknowledge the receipt of a manuscript, or who failed to publish after agreeing to do so, or who otherwise made things difficult for anthors.

Some of us also know of cases of outright editorial misbehavior. In ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies